Single-cycle parainfluenza virus type 5 vectors for producing recombinant proteins, including a humanized anti-V5 tag antibody

References

1. Schütz A, Bernhard F, Berrow N, Buyel JF, Ferreira-da-Silva F et al. A concise guide to choosing suitable gene expression systems for recombinant protein production. STAR Protoc 2023; 4:102572 [View Article] [PubMed]
   [Google Scholar]
2. Rima BK, Gatherer D, Young DF, Norsted H, Randall RE et al. Stability of the parainfluenza virus 5 genome revealed by deep sequencing of strains isolated from different hosts and following passage in cell culture. J Virol 2014; 88:3826–3836 [View Article] [PubMed]
   [Google Scholar]
3. Hsiung GD. Parainfluenza-5 virus. Infection of man and animal. Prog Med Virol 1972; 14:241–274 [PubMed]
   [Google Scholar]
4. Kim J-M, Kim H-R, Jeon G-T, Baek J-S, Kwon O-D et al. Molecular detection of porcine parainfluenza virus 1 and 5 using a newly developed duplex real-time RT-PCR in South Korea. Animals 2023; 13:598 [View Article] [PubMed]
   [Google Scholar]
5. Johnson RI, Tachedjian M, Rowe B, Clayton BA, Layton R. Alston virus, a novel paramyxovirus isolated from bats causes upper respiratory tract infection in experimentally challenged ferrets. Viruses 2018; 10:675 [View Article] [PubMed]
   [Google Scholar]
6. Parks GD, Manuse MJ, Johnson JB. The parainfluenza virus simian virus 5. In Samal SK. eds The Biology of Paramyxoviruses Norfolk, UK: Caister Academic Press; 2011 pp 37–68
   [Google Scholar]
7. Lamb RAaGDP. Paramyxoviridae: The Viruses and Their Replication, 6th ed Philadelphia: Lippincott, Williams and Wilkins; 2013 pp 957–995
   [Google Scholar]
8. Young DF, Wignall-Fleming EB, Busse DC, Pickin MJ, Hankinson J et al. The switch between acute and persistent paramyxovirus infection caused by single amino acid substitutions in the RNA polymerase P subunit. PLoS Pathog 2019; 15:e1007561 [View Article] [PubMed]
   [Google Scholar]
9. Randall RE, Young DF, Hughes DJ, Goodbourn S. Persistent paramyxovirus infections: in co-infections the parainfluenza virus type 5 persistent phenotype is dominant over the lytic phenotype. J Gen Virol 2023; 104:001916 [View Article] [PubMed]
   [Google Scholar]
10. Ellis JA, Krakowka GS. A review of canine parainfluenza virus infection in dogs. J Am Vet Med Assoc 2012; 240:273–284 [View Article] [PubMed]
    [Google Scholar]
11. Chen Z. Parainfluenza virus 5-vectored vaccines against human and animal infectious diseases. Rev Med Virol 2018; 28:e1965 [View Article] [PubMed]
    [Google Scholar]
12. An D, Li K, Rowe DK, Diaz MCH, Griffin EF et al. Protection of K18-hACE2 mice and ferrets against SARS-CoV-2 challenge by a single-dose mucosal immunization with a parainfluenza virus 5-based COVID-19 vaccine. Sci Adv 2021; 7:eabi5246 [View Article] [PubMed]
    [Google Scholar]
13. Spearman P, Jin H, Knopp K, Xiao P, Gingerich MC et al. Intranasal parainfluenza virus type 5 (PIV5)-vectored RSV vaccine is safe and immunogenic in healthy adults in a phase 1 clinical study. Sci Adv 2023; 9:eadj7611 [View Article] [PubMed]
    [Google Scholar]
14. Hanke T, Szawlowski P, Randall RE. Construction of solid matrix-antibody-antigen complexes containing simian immunodeficiency virus p27 using tag-specific monoclonal antibody and tag-linked antigen. J Gen Virol 1992; 73 (Pt 3):653–660 [View Article] [PubMed]
    [Google Scholar]
15. Dunn C, O’Dowd A, Randall RE. Fine mapping of the binding sites of monoclonal antibodies raised against the Pk tag. J Immunol Methods 1999; 224:141–150 [View Article] [PubMed]
    [Google Scholar]
16. Southern JA, Young DF, Heaney F, Baumgärtner WK, Randall RE. Identification of an epitope on the P and V proteins of simian virus 5 that distinguishes between two isolates with different biological characteristics. J Gen Virol 1991; 72 (Pt 7):1551–1557 [View Article] [PubMed]
    [Google Scholar]
17. Randall RE, Young DF, Goswami KK, Russell WC. Isolation and characterization of monoclonal antibodies to simian virus 5 and their use in revealing antigenic differences between human, canine and simian isolates. J Gen Virol 1987; 68 (Pt 11):2769–2780 [View Article] [PubMed]
    [Google Scholar]
18. Buchholz UJ, Finke S, Conzelmann KK. Generation of bovine respiratory syncytial virus (BRSV) from cDNA: BRSV NS2 is not essential for virus replication in tissue culture, and the human RSV leader region acts as a functional BRSV genome promoter. J Virol 1999; 73:251–259 [View Article] [PubMed]
    [Google Scholar]
19. Lo YT, Tulloch F, Wu HC, Luke GA, Ryan MD et al. Expression and immunogenicity of secreted forms of bovine ephemeral fever virus glycoproteins applied to subunit vaccine development. J Appl Microbiol 2021; 131:1123–1135 [View Article] [PubMed]
    [Google Scholar]
20. He B, Paterson RG, Ward CD, Lamb RA. Recovery of infectious SV5 from cloned DNA and expression of a foreign gene. Virology 1997; 237:249–260 [View Article] [PubMed]
    [Google Scholar]
21. Randall RE, Dinwoodie N. Intranuclear localization of herpes simplex virus immediate-early and delayed-early proteins: evidence that ICP 4 is associated with progeny virus DNA. J Gen Virol 1986; 67 (Pt 10):2163–2177 [View Article] [PubMed]
    [Google Scholar]
22. Carlos TS, Fearns R, Randall RE. Interferon-induced alterations in the pattern of parainfluenza virus 5 transcription and protein synthesis and the induction of virus inclusion bodies. J Virol 2005; 79:14112–14121 [View Article] [PubMed]
    [Google Scholar]
23. Randall RE, Young DF. Humoral and cytotoxic T cell immune responses to internal and external structural proteins of simian virus 5 induced by immunization with solid matrix-antibody-antigen complexes. J Gen Virol 1988; 69 (Pt 10):2505–2516 [View Article] [PubMed]
    [Google Scholar]
24. Randall RE. Preparation and uses of immunoabsorbent monolayers in the purification of virus proteins and separation of cells on the basis of their cell surface antigens. J Immunol Methods 1983; 60:147–165 [View Article] [PubMed]
    [Google Scholar]
25. Donnelly MLL, Hughes LE, Luke G, Mendoza H, Ten Dam E et al. The “cleavage” activities of foot-and-mouth disease virus 2A site-directed mutants and naturally occurring “2A-like” sequences. J Gen Virol 2001; 82:1027–1041 [View Article] [PubMed]
    [Google Scholar]
26. Minskaia E, Ryan MD. Protein coexpression using FMDV 2A: effect of “linker” residues. Biomed Res Int 2013; 2013:291730 [View Article] [PubMed]
    [Google Scholar]
27. Young DF, Chatziandreou N, He B, Goodbourn S, Lamb RA et al. Single amino acid substitution in the V protein of simian virus 5 differentiates its ability to block interferon signaling in human and murine cells. J Virol 2001; 75:3363–3370 [View Article] [PubMed]
    [Google Scholar]
28. Tihanyi B, Nyitray L. Recent advances in CHO cell line development for recombinant protein production. Drug Discov Today Technol 2020; 38:25–34 [View Article] [PubMed]
    [Google Scholar]
29. Clincke M-F, Mölleryd C, Samani PK, Lindskog E, Fäldt E et al. Very high density of Chinese hamster ovary cells in perfusion by alternating tangential flow or tangential flow filtration in WAVE bioreactor—Part II: applications for antibody production and cryopreservation. Biotechnol Prog 2013; 29:768–777 [View Article] [PubMed]
    [Google Scholar]
30. Xu WJ, Lin Y, Mi CL, Pang JY, Wang TY. Progress in fed-batch culture for recombinant protein production in CHO cells. Appl Microbiol Biotechnol 2023; 107:1063–1075 [View Article] [PubMed]
    [Google Scholar]
31. Nakanishi M, Otsu M. Development of Sendai virus vectors and their potential applications in gene therapy and regenerative medicine. Curr Gene Ther 2012; 12:410–416 [View Article] [PubMed]
    [Google Scholar]
32. Nosaka T, Ohtsuka J, Ohtsuka T, Fukumura M. Next generation RNA/protein-carrying vector with pleiotropic activity. Rev Med Virol 2024; 34:e70008 [View Article] [PubMed]
    [Google Scholar]
33. Wignall-Fleming EB, Hughes DJ, Vattipally S, Modha S, Goodbourn S et al. Analysis of paramyxovirus transcription and replication by high-throughput sequencing. J Virol 2019; 93:e00571-19 [View Article] [PubMed]
    [Google Scholar]